Basic Information
RNALocate ID: | RLID-D:11000196 |
RNA Symbol: | hsa-miR-26a-2-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-26a-2-3p |
RNA ID: | miRBase:MIMAT0004681 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003877 | Exosome | Plasma | 23663360 |
RLID:11003878 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID-D:11000657 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-26a-2-3p | Colorectal adenoma | MNDR-E-MI-33031 |
MNDR | hsa-miR-26a-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33032 |
MNDR | hsa-miR-26a-2-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33033 |
MNDR | hsa-miR-26a-2-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33034 |
MNDR | hsa-miR-26a-2-3p | Gastric cancer | MNDR-E-MI-33035 |
MNDR | hsa-miR-26a-2-3p | Alzheimer disease | MNDR-E-MI-33036 |
MNDR | hsa-miR-26a-2-3p | Head and neck cancer | MNDR-E-MI-33037 |
MNDR | hsa-miR-26a-2-3p | Leukemia | MNDR-E-MI-33038 |
MNDR | hsa-miR-26a-2-3p | Lung cancer | MNDR-E-MI-33039 |
MNDR | hsa-miR-26a-2-3p | Parkinson disease | MNDR-E-MI-33040 |
MNDR | hsa-miR-26a-2-3p | Colonic adenomas | MNDR-E-MI-33041 |
MNDR | hsa-miR-26a-2-3p | Breast cancer | MNDR-E-MI-33042 |
MNDR | hsa-miR-26a-2-3p | Nephroblastoma | MNDR-E-MI-33043 |
MNDR | hsa-miR-26a-2-3p | Colon cancer | MNDR-E-MI-33044 |
MNDR | hsa-miR-26a-2-3p | Colon adenocarcinoma | MNDR-E-MI-33045 |
MNDR | hsa-miR-26a-2-3p | Familial ovarian cancer | MNDR-E-MI-33046 |
MNDR | hsa-miR-26a-2-3p | Glioblastoma | MNDR-E-MI-33047 |
MNDR | hsa-miR-26a-2-3p | Malignant glioma | MNDR-E-MI-33048 |
MNDR | hsa-miR-26a-2-3p | Gastric adenocarcinoma | MNDR-E-MI-33049 |
MNDR | hsa-miR-26a-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-33050 |
MNDR | hsa-miR-26a-2-3p | Lung adenocarcinoma | MNDR-E-MI-33051 |
MNDR | hsa-miR-26a-2-3p | Thyroid carcinoma | MNDR-E-MI-33052 |
MNDR | hsa-miR-26a-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-33053 |
MNDR | hsa-miR-26a-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-33054 |
MNDR | hsa-miR-26a-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33055 |
MNDR | hsa-miR-26a-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-33056 |
MNDR | hsa-miR-26a-2-3p | Testicular germ cell cancer | MNDR-E-MI-33057 |
MNDR | hsa-miR-26a-2-3p | T acute lymphoblastic leukemia | MNDR-E-MI-33058 |
MNDR | hsa-miR-26a-2-3p | Acute t cell leukemia | MNDR-E-MI-33059 |
MNDR | hsa-miR-26a-2-3p | Adenoma | MNDR-E-MI-33060 |
MNDR | hsa-miR-26a-2-3p | Hepatocellular carcinoma | MNDR-E-MI-33061 |
MNDR | hsa-miR-26a-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-33062 |
MNDR | hsa-miR-26a-2-3p | Skin cutaneous melanoma | MNDR-E-MI-33063 |
MNDR | hsa-miR-26a-2-3p | Skin melanoma | MNDR-E-MI-33064 |
MNDR | hsa-miR-26a-2-3p | Acute myelocytic leukemia | MNDR-E-MI-33065 |
MNDR | hsa-miR-26a-2-3p | Colorectal cancer | MNDR-E-MI-33066 |
MNDR | hsa-miR-26a-2-3p | Nasopharynx carcinoma | MNDR-E-MI-33067 |
MNDR | hsa-miR-26a-2-3p | Multiple myeloma | MNDR-E-MI-33068 |
MNDR | hsa-miR-26a-2-3p | Nasopharyngeal cancer | MNDR-E-MI-33069 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | IL10 | Homo sapiens | RR00746234 |
TOP